ASH Medical Educators Institute: A View From the Classroom
Dr. Laura Michaelis interviews Drs. Molly Mandernach and Annie Im about their experience participating in the ASH Medical Educators Institute.
Germline Mutations in a Cohort of Inherited Marrow Failure Patients: A Varied Landscape
Dr. Keel reviews work that expands our understanding of the inherited genetic underpinnings of marrow failure and hematologic malignancy predisposition.
Dr. Maese and Dr. Raetz review several studies that have defined the scope and magnitude of medication nonadherence in childhood ALL including the fact that one-third of ALL relapses are attributed to 6-MP nonadherence. They stress the need for simplification of 6-MP delivery instructions.
Dr. Raetz looks at the use of gemtuzumab ozogamicin (CO) for the treatment of acute myeloid leukemia in adults and children.
Dr. Raetz looks at a study that shows response-based therapy in both children and adults with ETP-ALL is effective.
Dr. Raetz discusses a report that provides important new insight into improving the accuracy of induction response assessment by incorporating MRD.
Dr. Raetz looks at a report that shows that Ph-like ALL is common across the age spectrum.
Drs. Raetz and Kovacsovics cover a trial meant to develop a precision medicine approach for the treatment of AML.
Dr. Raetz reviews changes that have emerged in 2016 in the treatment of acute lymphocytic leukemia for both children and adults.
Dr. Raetz looks at a highly promising new monoclonal antibody therapy for CD22-positive B-cell acute lymphoblastic leukemia.
Dr. Raetz looks at the possibility of therapy reduction in carefully defined good risk subsets due to improvements in acute lymphoblastic leukemia outcomes.
Dr. Raetz compares dexamethasone and prednisone for the induction phase of treatment of childhood acute lymphocytic leukemia.
March-April 2018Volume 15, Issue 2
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology